Predicting future shocks in implantable cardioverter defibrillator recipients: the role of biomarkers.
Simple clinical and laboratory indexes have been identified as predictors of arrhythmic events in implantable cardioverter defibrillator patients. Biomarkers, which are playing a growing role in the prognosis and treatment of patients with heart failure, could provide an auxiliary tool in this context, given that their measurement is now easy and widely available.
Kanoupakis
Emmanuel M
EM
Department of Cardiology, University Hospital of Heraklion, Crete, Greece.
Manios
Emmanuel G
EG
Vardas
Panos E
PE
D015415:Biomarkers / Q000097:blood*; D016207:Cytokines / Q000097:blood*; D017147:Defibrillators, Implantable / Q000009:adverse effects*; D004556:Electric Injuries / Q000097:blood / Q000175:diagnosis* / Q000209:etiology*; D006801:Humans; D045726:Metalloproteases / Q000097:blood*; D045265:Natriuretic Peptides / Q000097:blood*; D011379:Prognosis; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors
D015415:Biomarkers; D016207:Cytokines; D045265:Natriuretic Peptides; D045726:Metalloproteases